April 29, 2011 | Filed under: Health,News | Posted by:
An early report of a new study shows that the first-generation bisphosphonate, Didronel, in combination with the cholesterol drug Lipitor, reduced abdominal aortic plaques by about 12% in people with high cholesterol, compared to 1% in people on Lipitor alone.
Posted by
on April 29, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on April 29, 2011. Filed under